Protection of crystal-induced polymorphonuclear leukocyte membranolysis by phosphocitrate

This publication has 12 references indexed in Scilit:

• A possible antiatherogenic role for phosphocitrate through modulation of low density lipoprotein uptake and degradation in aortic smooth muscle cells
  Atherosclerosis, 1987
• Crystal-induced membrane damage: Hydroxyapatite crystal-induced hemolysis of erythrocytes
  Biochemical Medicine and Metabolic Biology, 1986
• Phosphocitrate and its analogue N-sulpho-2-amino tricarballylate inhibit aortic calcification
  Atherosclerosis, 1984
• Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation
  Calcified Tissue International, 1982
• Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the hypaque-ficoll method
  Journal of Immunological Methods, 1980
• Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxylapatite crystal growth
  Biochemistry, 1980
• The synthesis of unlabeled and 32P-labeled phosphocitrate and analytical systems for its identification
  Analytical Biochemistry, 1980
• Pathogenesis of Crystal-Induced Synovitis
  Clinics in Rheumatic Diseases, 1977
• Effect of Stannous and Fluoride Ions on the Rate of Crystal Growth of Hydroxyapatite
  Journal of Dental Research, 1972
• AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINS
  Transplantation, 1968